Products found to contain undeclared medicines
|
| |
| The United States: Public Notification: Tawon Liar contains hidden drug ingredients meloxicam, ketorolac and dexamethasone |
| |
The US Food and Drug Administration (FDA) continues to advise consumers not to purchase or use Tawon Liar, a product promoted and sold for pain, rheumatism, insomnia, improving the immune system, increasing energy and lowering cholesterol on various websites and possibly in some retail stores.
FDA laboratory analysis confirmed that Tawon Liar contains meloxicam, ketorolac and dexamethasone. Meloxicam and ketorolac are non-steroidal anti-inflammatory drugs (NSAIDs). NSAIDs may cause increased risk of cardiovascular events, such as heart attack and stroke, as well as serious gastrointestinal damage, including bleeding, ulceration and fatal perforation of the stomach and intestines. These hidden drug ingredients may also interact with other medications and significantly increase the risk of adverse events, particularly when consumers use multiple NSAID-containing products.
Dexamethasone is a corticosteroid commonly used to treat inflammatory conditions. Corticosteroid use can impair a person’s ability to fight infections and can cause high blood sugar levels, muscle injuries and psychiatric problems. When corticosteroids are taken for a prolonged period, or at high doses, they can suppress the adrenal gland. Abrupt discontinuation can cause withdrawal symptoms.
Please refer to the following website in FDA for details:
http://www.fda.gov/drugs/medication-health-fraud/public-notification-tawon-liar-contains-hidden-drug-ingredient
In Hong Kong, the above product is not a registered pharmaceutical product. Related news was previously issued by FDA, and was posted on the Drug Office website on 8 Jan 2022.
Ends/Friday, Feb 17, 2023
Issued at HKT 14:30
|
| |
|
